These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 11218242)
1. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Belaiche J; Desager JP; Horsmans Y; Louis E Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242 [TBL] [Abstract][Full Text] [Related]
2. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry. Zochowska D; Zegarska J; Hryniewiecka E; Samborowska E; Jazwiec R; Tszyrsznic W; Borowiec A; Dadlez M; Paczek L Transplant Proc; 2016 Jun; 48(5):1836-9. PubMed ID: 27496503 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [TBL] [Abstract][Full Text] [Related]
4. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Cuffari C; Théorêt Y; Latour S; Seidman G Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease. Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169 [TBL] [Abstract][Full Text] [Related]
6. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197 [TBL] [Abstract][Full Text] [Related]
7. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046 [TBL] [Abstract][Full Text] [Related]
8. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696 [TBL] [Abstract][Full Text] [Related]
9. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease. Goldenberg BA; Rawsthorne P; Bernstein CN Am J Gastroenterol; 2004 Sep; 99(9):1744-8. PubMed ID: 15330913 [TBL] [Abstract][Full Text] [Related]
10. Determination of 6-thioguanine and 6-methylmercaptopurine metabolites in renal transplantation recipients and patients with glomerulonephritis treated with azathioprine. Chrzanowska M; Krzymański M Ther Drug Monit; 1999 Apr; 21(2):231-7. PubMed ID: 10217345 [TBL] [Abstract][Full Text] [Related]
11. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients. Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547 [TBL] [Abstract][Full Text] [Related]
12. RBC 6-TGN and hematological parameters in patients with Crohn's disease treated by azathioprine. D'Halluin PN; Tribut O; Branger B; Lebreton C; Bretagne JF; Bentue-Ferrer D; Heresbach D Gastroenterol Clin Biol; 2005 Dec; 29(12):1264-9. PubMed ID: 16518285 [TBL] [Abstract][Full Text] [Related]
14. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD. Spencer E; Norris E; Williams C; Dubinsky MC Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603 [TBL] [Abstract][Full Text] [Related]
15. Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood. Pike MG; Franklin CL; Mays DC; Lipsky JJ; Lowry PW; Sandborn WJ J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(1):1-9. PubMed ID: 11419732 [TBL] [Abstract][Full Text] [Related]
19. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine. Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439 [TBL] [Abstract][Full Text] [Related]
20. 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial. Reinshagen M; Schütz E; Armstrong VW; Behrens C; von Tirpitz C; Stallmach A; Herfarth H; Stein J; Bias P; Adler G; Shipkova M; Kruis W; Oellerich M; von Ahsen N Clin Chem; 2007 Jul; 53(7):1306-14. PubMed ID: 17495015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]